Erythromycin blocks the rapid component of the delayed rectifier potassium current and lengthens repolarization of guinea pig ventricular myocytes

Circulation

Volumn 91, Issue 12, 1995, Pages 3010-3016

  Daleau, Pascal ^a   Lessard, Etienne ^a   Groleau, Marie France ^a   Turgeon, Jacques ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

action potentials; calcium channels; potassium; torsade de pointes

Indexed keywords

CALCIUM CHANNEL; ERYTHROMYCIN;

ACTION POTENTIAL; ADRENERGIC SYSTEM; AFTERHYPERPOLARIZATION; ARTICLE; CALCIUM CURRENT; DRUG EFFECT; GUINEA PIG; HEART MUSCLE CELL; HEART REPOLARIZATION; HUMAN; HUMAN TISSUE; ISOLATED HEART; MALE; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; TORSADE DES POINTES;

EID: 0029066446     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.91.12.3010     Document Type: Article

References (24)

1. McComb JM, Campbell NPS, Cleland J. Recurrent ventricular tachycardia associated with QT prolongation after mitral valve replacement and its association with intravenous administration of erythromycin. Am J Cardiol. 1984;54:922-923.
2. Freedman RA, Anderson KP, Green LS, Mason JW. Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome. Am J Cardiol. 1987;59: 168-169.
3. Nattel S, Ranger S, Talajic M, Lemery R, Roy D. Erythromycin-induced long QT syndrome: concordance with quinidine and underlying cellular electrophysiologic mechanism. Am J Med. 1990;89:235-238.
4. Farrar HC, Walsh-Sukys MC, Kyllonen K, Blumer JL. Cardiac toxicity associated with intravenous erythromycin lactobionate: two case reports and a review of the literature. Pediatr Infect Dis J. 1993;12:688-691.
5. Guelon D, Bedock B, Chartier C, Haberer JP. QT prolongation and recurrent 'torsades de pointes' during erythromycin lactobionate infusion. Am J Cardiol. 1986;58:666.
6. Brandriss MW, Richardson WS, Barold SS. Erythromycin-induced QT prolongation and polymorphic ventricular tachycardia (torsades de pointes): case report and review. Clin Infect Dis. 1994;18: 995-998.
7. Honig PK, Woosley RL, Zamani K, Conner DP, Cantilena LR. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther. 1992;52:231-238.
8. Rubart M, Pressler ML, Pride HP, Zipes DP. Electrophysiological mechanisms in a canine model of erythromycin-associated long QT syndrome. Circulation. 1993;88:1832-1844.
9. Zhang ZQ, Antzelevitch C. Erythromycin produces prominent action potential prolongation and early afterdepolarization (EAD)-induced triggered activity in M but not epicardial or endocardial regions of the canine ventricle. Circulation. 1993;88(suppl I):I-327. Abstract.
10. Franz MR, Burkhoff D, Spurgeon H, Weisfeldt ML, Lakatta EG. In vitro validation of a new cardiac catheter technique for recording monophasic action potentials. Eur Heart J. 1986;7:34-41.
11. Franz MR, Chin MC, Sharkey HR, Griffin JC, Scheinman MM. A new single catheter technique for simultaneous measurement of action potential duration and refractory period in vivo. J Am Coll Cardiol. 1990;16:878-886.
12. Kr: 67th Annual Scientific Session, American Heart Association Meeting. Circulation. 1994;90(suppl I):I-248. Abstract.
13. + currents. Pflugers Arch. 1992;420:180-186.
14. Srivastava MS, Carter EM. An Introduction to Applied Multivariate Statistics. New York, NY: Elsevier Science Publishing Co, Inc; 1983.
15. + current: differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol. 1990;96:195-215.
16. Austin KL, Mather LE, Philpot CR, McDonald PJ. Intersubject and dose related variability after intravenous administration of erythromycin. Br J Clin Pharmacol. 1980;10:273-279.
17. K) in guinea pig ventricular myocytes. Circ Res. 1994;74:1114-1120.
18. Valenzuela C, Sanchez-Chapula J, Delpon E, Elizalde A, Ferez O, Tamargo J. Imipramine blocks rapidly activating and delays slowly activating K+ current activation in guinea pig ventricular myocytes. Circ Res. 1994;74:687-699.
19. Litovsky SH, Antzelevitch C. Transient outward current prominent in canine ventricular epicardium but not endocardium. Circ Res. 1988;62:116-126.
20. Litovsky SH, Antzelevitch C. Rate dependence of action potential duration and refractoriness in canine ventricular endocardium differs from that of epicardium: role of the transient outward current. J Am Coll Cardiol. 1989;14:1053-1066.
21. Sicouri S, Antzelevitch C. A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. Circ Res. 1991;68:1729-1741.
22. Chinn K. Two delayed rectifiers in guinea pig ventricular myocytes distinguished by tail current kinetics. J Pharmacol Exp Ther. 1993; 264:553-560.
23. Courtney KR. Sodium channel blockers: the size/solubility hypothesis revisited. Mol Pharmacol. 1990;37:855-859.
24. + channel cloned from human heart. Mol Pharmacol. 1993;44:1240-1245.